Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 1, 2013, Pages 68-73

  Renaud, Stéphane ^a   Falcoz, Pierre Emmanuel ^a   Olland, Anne ^a   Massard, Gilbert ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

Non small cell lung cancer; Radiation therapy; Radiofrequency; Stereotactic radiotherapy

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; META ANALYSIS (TOPIC); MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PNEUMOTHORAX; PRIORITY JOURNAL; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; SYSTEMATIC REVIEW;

BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871753874     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs423     Document Type: Article

References (23)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9. (Pubitemid 38112771)
2. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
3. Onimaru R, Shimizu S, Kitamuru K, Xu B, Fukumoto S, Chang TC et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-35. (Pubitemid 36403684)
4. Lee SW, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003;40:309-15. (Pubitemid 36627711)
5. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124: 1946-55. (Pubitemid 37433596)
6. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metas-tases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-96. (Pubitemid 39165484)
7. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiation therapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;5:1427-31. (Pubitemid 41628038)
8. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA et al. Stereotactic body radiation therapy for early stage non-small cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;3:667-82.
9. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-6.
10. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
11. Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R et al. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol 2011;101:245-9.
12. Onishi H, Shirato H, Nagata Y, Hirakoa M, Fujino M, Gomi K et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
13. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 2004;101:1623-31. (Pubitemid 39318910)
14. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K et al. Hypofractioned stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2(7 Suppl 3):S94-100.
15. Verstegen NE, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011;101:250-4.
16. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:348-53.
17. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol 2012; 13:802-9.
18. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010;95:32-40.
19. Belfiore G, Moggio G, Tedeschi E, Greco M, Cioffi R, Cincotti F et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer: a preliminary report of 33 patients. Am J Roentgenol 2004;183:1003-11. (Pubitemid 44185086)
20. Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005;129:639-44. (Pubitemid 40311325)
21. Hiraki T, Gobara H, Ishi T, Sano Y, Iguchi T, Fukiwara H et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007;134:1306-12. (Pubitemid 47633617)
22. Lanuti M, Sharma A, Digurmarthy SR, Wright CD, Donahue DM, Wain JC et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:160-6.
23. Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007;134: 857-64. (Pubitemid 47454625)